Jove
Visualize
Contact Us

Related Experiment Videos

Towards a model stroke trial. The single-centre naftidrofuryl study.

T J Steiner, F Clifford Rose

    Neuroepidemiology
    |January 1, 1986
    PubMed
    Summary

    Naftidrofuryl treatment shows promise for acute cerebral infarction (ACI). This study found significant improvements in neurological recovery and functional outcomes, suggesting a beneficial role for the drug in managing ACI.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Time is of the essence in headache measurement. A response to Gil-Gouveia.

    The journal of headache and pain·2022
    Same author

    Editorial. Valuing headache's solution.

    The journal of headache and pain·2021
    Same author

    Headache service quality evaluation: implementation of quality indicators in primary care in Europe.

    The journal of headache and pain·2021
    Same author

    Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019.

    The journal of headache and pain·2020
    Same author

    Aids to management of headache disorders in primary care (2nd edition) : on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache.

    The journal of headache and pain·2019
    Same author

    Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence.

    The journal of headache and pain·2019
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Neurology
    • Pharmacology
    • Clinical Trials

    Background:

    • Acute cerebral infarction (ACI) lacks proven pharmacological treatments, raising questions about drug efficacy versus assessment methods.
    • Re-evaluation of trials suggests assessment inadequacies may contribute to the lack of effective treatments for ACI.

    Purpose of the Study:

    • To expound a rationale for naftidrofuryl treatment in ACI based on current understanding.
    • To discuss guidelines for clinical trial design in acute stroke, addressing challenges like early treatment initiation and diagnostic confirmation.
    • To test these guidelines in a clinical trial of naftidrofuryl.

    Main Methods:

    • A single-center clinical trial involving 100 patients with proven ACI diagnoses.
    • Rigorous attention to patient selection, treatment administration, and follow-up procedures.
    • An explanatory trial design approach to predict a positive result if the drug was effective.

    Main Results:

    • Naftidrofuryl treatment did not alter the death rate in ACI patients.
    • Clinically and statistically significant improvements were observed in neurological recovery and bed occupancy.
    • Enhanced functional recovery was also noted, supporting the coherence of the trial findings.

    Conclusions:

    • The study recorded a beneficial effect of naftidrofuryl in managing acute cerebral infarction.
    • The results are consistent with previous studies, supporting a potential role for naftidrofuryl.
    • Further research is recommended to precisely define naftidrofuryl's role in ACI management.

    Related Experiment Videos